Nektar Therapeutics says no cash deposits, securities at Silicon Valley Bank

Nektar Therapeutics (NKTR) issued a statement confirming that it does not have any accounts at Silicon Valley Bank (SIVB), and it does not hold any cash deposits or securities at Silicon Valley Bank. At December 31, 2022, the company had approximately $505 million in cash and investments in marketable securities.